Fractional exhaled nitric oxide in asthma: An update

Respirology

Volumn 15, Issue 1, 2010, Pages 57-70

  Sandrini, Alessandra ^a   Taylor, D Robin ^d   Thomas, Paul S ^b,c   Yates, Deborah H ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Airway inflammation; Asthma; Eosinophil; Eosinophilic inflammation; Inhaled steroid; Non invasive monitoring

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; GLUCOCORTICOID; NITRIC OXIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ASTHMA; ATOPY; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CYSTIC FIBROSIS; DISEASE CONTROL; HUMAN; LUNG TUBERCULOSIS; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REFERENCE VALUE; REVIEW; SARCOIDOSIS; SYSTEMIC SCLEROSIS;

ADRENAL CORTEX HORMONES; ASTHMA; BREATH TESTS; CLINICAL TRIALS AS TOPIC; EOSINOPHILS; EXHALATION; HUMANS; NITRIC OXIDE;

EID: 74049127878     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01616.x     Document Type: Review

References (172)

1. Wright BM, McKerrow CB. Maximum forced expiratory flow rate as a measure of ventilatory capacity: with a description of a new portable instrument for measuring it. BMJ 1959 21 : 1041 1046.
2. Busse WW, Lemanske RF Jr. Asthma. N. Engl. J. Med. 2001 344 : 350 362.
3. Kay AB. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 2001 344 : 30 7.
4. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am. J. Respir. Crit. Care Med. 1997 156 : 737 743.
5. Wenzel SE. Severe asthma in adults. Exp. Lung Res. 2005 31 (Suppl. 1 22.
6. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006 368 : 804 813.
7. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol. Today 1999 20 : 528 533.
8. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am. Rev. Respir. Dis. 1987 136 : 740 751.
9. Kharitonov SA, Barnes PJ. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2004 1 : 191 199.
10. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 1993 147 : 697 704.
11. Boulet LP, Turcotte H, Laviolette M, Naud F, Bernier MC et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 2000 162 : 1308 1313.
12. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC et al. Airway inflammation is present during clinical remission of atopic asthma. Am. J. Respir. Crit. Care Med. 2001 164 : 2107 2113.
13. Smith H. Asthma, inflammation, eosinophils and bronchial hyperresponsiveness. Clin. Exp. Allergy 1992 22 : 187 197.
14. Bentley AM, Menz G, Storz C, Robinson DS, Bradley B et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am. Rev. Respir. Dis. 1992 146 : 500 506.
15. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 1988 137 : 62 9.
16. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 1996 154 : 308 317.
17. Pavord ID, Chung KF. Management of chronic cough. Lancet 2008 371 : 1375 1384.
18. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999 353 : 2213 2214.
19. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002 360 : 1715 1721.
20. Wark PA, Simpson JL, Hensley MJ, Gibson PG. Safety of sputum induction with isotonic saline in adults with acute severe asthma. Clin. Exp. Allergy 2001 31 : 1745 1753.
21. Nightingale JA, Rogers DF, Barnes PJ. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax 1998 53 : 87 90.
22. Deykin A, Massaro AF, Drazen JM, Israel E. Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am. J. Respir. Crit. Care Med. 2002 165 : 1597 1601.
23. Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur. Respir. J. 2003 21 : 433 438.
24. van Veen IH, Ten Brinke A, Sterk PJ, Sont JK, Gauw SA et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur. Respir. J. 2008 32 : 344 349.
25. Silkoff PE. Monitoring nitric oxide: here to stay for bench and bedside. Eur. Respir. J. 2005 25 : 949 950.
26. Bates CA, Silkoff PE. Exhaled nitric oxide in asthma: from bench to bedside. J. Allergy Clin. Immunol. 2003 111 : 256 262.
27. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987 327 : 524 526. (Pubitemid 17085822)
28. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 1987 84 : 9265 9269.
29. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993 329 : 2002 2012.
30. Culotta E, Koshland DE Jr. NO news is good news. Science 1992 258 : 1862 1865.
31. Belvisi MG, Miura M, Stretton D, Barnes PJ. Endogenous vasoactive intestinal peptide and nitric oxide modulate cholinergic neurotransmission in guinea-pig trachea. Eur. J. Pharmacol. 1993 231 : 97 102. (Pubitemid 23039550)
32. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993 48 : 1034 1043.
33. Gustafsson LE. Exhaled nitric oxide as a marker in asthma. Eur. Respir. J. Suppl. 1998 26 : 49S 52S.
34. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 1994 149 : 538 551.
35. Kerwin JF Jr., Heller M. The arginine-nitric oxide pathway: a target for new drugs. Med. Res. Rev. 1994 14 : 23 74.
36. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994 78 : 915 918.
37. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS et al. Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol. Dial. Transplant. 2000 15 : 1794 1800.
38. Mollsten A, Wessman M, Svensson M, Forsblom C, Parkkonen M et al. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Ann. Med. 2006 38 : 522 528.
39. Dweik RA. Nitric oxide, hypoxia, and superoxide: the good, the bad, and the ugly! Thorax 2005 60 : 265 267.
40. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol. 1993 9 : 371 377.
41. Lane C, Knight D, Burgess S, Franklin P, Horak F et al. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 2004 59 : 757 760.
42. Redington AE, Meng QH, Springall DR, Evans TJ, Creminon C et al. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax 2001 56 : 351 357.
43. Batra J, Pratap Singh T, Mabalirajan U, Sinha A, Prasad R et al. Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels. Thorax 2007 62 : 16 22.
44. Gao PS, Kawada H, Kasamatsu T, Mao XQ, Roberts MH et al. Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem. Biophys. Res. Commun. 2000 267 : 761 763.
45. Wechsler ME, Grasemann H, Deykin A, Silverman EK, Yandava CN et al. Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. Am. J. Respir. Crit. Care Med. 2000 162 : 2043 2047.
46. Thomas PS, Bruce C, Birkhead A, Wang XL. Effect of ecNOS polymorphisms and coronary artery disease upon exhaled nitric oxide. J. Mol. Med. 2002 80 : 181 186.
47. Yates DH, Kharitonov SA, Thomas PS, Barnes PJ. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 1996 154 : 247 250.
48. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur. Respir. J. 1997 10 : 1683 1693.
49. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am. J. Respir. Crit. Care Med. 1999 160 : 2104 2117.
50. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxid, 2005. Am. J. Respir. Crit. Care Med. 2005 171 : 912 930.
51. Lehtimaki L, Kankaanranta H, Saarelainen S, Hahtola P, Jarvenpaa R et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am. J. Respir. Crit. Care Med. 2001 163 : 1557 1561.
52. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 2007 131 : 1353 1362.
53. Paraskakis E, Brindicci C, Fleming L, Krol R, Kharitonov SA et al. Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am. J. Respir. Crit. Care Med. 2006 174 : 260 267.
54. Ekroos H, Karjalainen J, Sarna S, Laitinen LA, Sovijarvi AR. Short-term variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects. Respir. Med. 2002 96 : 895 900.
55. Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E et al. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J. Allergy Clin. Immunol. 2004 114 : 1241 1256.
56. Borrill Z, Clough D, Truman N, Morris J, Langley S et al. A comparison of exhaled nitric oxide measurements performed using three different analysers. Respir. Med. 2006 100 : 1392 1396.
57. Muller KC, Jorres RA, Magnussen H, Holz O. Comparison of exhaled nitric oxide analysers. Respir. Med. 2005 99 : 631 637.
58. Khalili B, Boggs PB, Bahna SL. Reliability of a new hand-held device for the measurement of exhaled nitric oxide. Allergy 2007 62 : 1171 1174.
59. Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement: comparison with the 'gold standard' technique. Chest 2007 131 : 410 414.
60. Alving K, Janson C, Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir. Res. 2006 7 : 67.
61. Buchvald F, Baraldi E, Carraro S, Gaston B, De Jongste J et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J. Allergy Clin. Immunol. 2005 115 : 1130 1136.
62. Kissoon N, Duckworth LJ, Blake KV, Murphy SP, Taylor CL et al. FE(NO): relationship to exhalation rates and online versus bag collection in healthy adolescents. Am. J. Respir. Crit. Care Med. 2000 162 : 539 545.
63. Franklin PJ, Taplin R, Stick SM. A community study of exhaled nitric oxide in healthy children. Am. J. Respir. Crit. Care Med. 1999 159 : 69 73.
64. Olivieri M, Talamini G, Corradi M, Perbellini L, Mutti A et al. Reference values for exhaled nitric oxide (reveno) study. Respir. Res. 2006 7 : 94.
65. Olin AC, Bake B, Toren K. Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest 2007 131 : 1852 1856.
66. Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am. J. Respir. Crit. Care Med. 2007 176 : 238 242.
67. Taylor DR, Mandhane P, Greene JM, Hancox RJ, Filsell S et al. Factors affecting exhaled nitric oxide measurements: the effect of sex. Respir. Res. 2007 8 : 82.
68. Jilma B, Kastner J, Mensik C, Vondrovec B, Hildebrandt J et al. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci. 1996 58 : 469 476.
69. Tsang KW, Ip SK, Leung R, Tipoe GL, Chan SL et al. Exhaled nitric oxide: the effects of age, gender and body size. Lung 2001 179 : 83 91.
70. Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B et al. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006 130 : 1319 1325.
71. McSharry CP, McKay IC, Chaudhuri R, Livingston E, Fraser I et al. Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma. J. Allergy Clin. Immunol. 2005 116 : 88 93.
72. Yates DH, Breen H, Thomas PS. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects. Am. J. Respir. Crit. Care. Med. 2001 164 : 1043 1046.
73. Olin AC, Aldenbratt A, Ekman A, Ljungkvist G, Jungersten L et al. Increased nitric oxide in exhaled air after intake of a nitrate-rich meal. Respir. Med. 2001 95 : 153 158. (Pubitemid 32624447)
74. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. The effect of alcohol ingestion on exhaled nitric oxide. Eur. Respir. J. 1996 9 : 1130 1133.
75. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 1995 152 : 892 896.
76. Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J. Pediatr. 1997 131 : 381 385.
77. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 1996 153 : 454 457.
78. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994 343 : 133 135.
79. Bisgaard H, Loland L, Oj JA. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am. J. Respir. Crit. Care Med. 1999 160 : 1227 1231.
80. Sandrini A, Ferreira IM, Gutierrez C, Jardim JR, Zamel N et al. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 2003 124 : 1334 1340.
81. Silkoff PE, Romero FA, Gupta N, Townley RG, Milgrom H. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody. Pediatrics 2004 113 : e308 12.
82. Yates DH, Kharitonov SA, Barnes PJ. Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients. Eur. Respir. J. 1997 10 : 1483 1488.
83. Silkoff PE, Wakita S, Chatkin J, Ansarin K, Gutierrez C et al. Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma. Am. J. Respir. Crit. Care Med. 1999 159 : 940 944.
84. Kissoon N, Duckworth LJ, Blake KV, Murphy SP, Lima JJ. Effect of beta2-agonist treatment and spirometry on exhaled nitric oxide in healthy children and children with asthma. Pediatr. Pulmonol. 2002 34 : 203 208.
85. Dinakar C, Van Osdol TJ, Barnes CS, Dowling PJ, Zeigler AW. Changes in exhaled nitric oxide levels with immunotherapy. Allergy Asthma Proc. 2006 27 : 140 144.
86. Roberts G, Hurley C, Turcanu V, Lack G. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J. Allergy Clin Immunol. 2006 117 : 263 268.
87. Girgis RE, Champion HC, Diette GB, Johns RA, Permutt S et al. Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy. Am. J. Respir. Crit. Care Med. 2005 172 : 352 357.
88. Piacentini GL, Bodini A, Peroni DG, Miraglia del Giudice M Jr., Costella S et al. Reduction in exhaled nitric oxide immediately after methacholine challenge in asthmatic children. Thorax 2002 57 : 771 773.
89. de Gouw HW, Hendriks J, Woltman AM, Twiss IM, Sterk PJ. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am. J. Respir. Crit. Care Med. 1998 158 : 315 319.
90. Bruce CT, Zhao D, Yates DH, Thomas PS. AMP challenge induces a decrease in FE(NO) in asthmatic subjects modulated by nedocromil. Eur. J. Clin. Invest. 2006 36 : 899 905.
91. Deykin A, Halpern O, Massaro AF, Drazen JM, Israel E. Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am. J. Respir. Crit. Care Med. 1998 157 : 769 775.
92. Thomassen MJ, Raychaudhuri B, Dweik RA, Farver C, Buhrow L et al. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J. Allergy Clin. Immunol. 1999 104 : 1174 1182.
93. Ihre E, Gyllfors P, Gustafsson LE, Kumlin M, Dahlen B. Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge. Eur. Respir. J. 2006 27 : 1152 1159.
94. Scollo M, Zanconato S, Ongaro R, Zaramella C, Zacchello F et al. Exhaled nitric oxide and exercise-induced bronchoconstriction in asthmatic children. Am. J. Respir. Crit. Care Med. 2000 161 : 1047 1050.
95. Riley MS, Porszasz J, Miranda J, Engelen MP, Brundage B et al. Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis. Chest 1997 111 : 44 50.
96. Phillips CR, Giraud GD, Holden WE. Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow. J. Appl. Physiol. 1996 80 : 1865 1871.
97. Oguzulgen IK, Turktas H, Erbas D. Airway inflammation in premenstrual asthma. J. Asthma 2002 39 : 517 522.
98. Morris NH, Sooranna SR, Steer PJ, Warren JB. The effect of the menstrual cycle on exhaled nitric oxide and urinary nitrate concentration. Eur. J. Clin. Invest. 1996 26 : 481 484.
99. Johannesson M, Ludviksdottir D, Janson C. Lung function changes in relation to menstrual cycle in females with cystic fibrosis. Respir. Med. 2000 94 : 1043 1046.
100. Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur. Respir. J. 1995 8 : 295 297.
101. van Amsterdam JG, Janssen NA, de Meer G, Fischer PH, Nierkens S et al. The relationship between exhaled nitric oxide and allergic sensitization in a random sample of school children. Clin. Exp. Allergy 2003 33 : 187 191.
102. Ho LP, Wood FT, Robson A, Innes JA, Greening AP. Atopy influences exhaled nitric oxide levels in adult asthmatics. Chest 2000 118 : 1327 1331.
103. Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J. Allergy Clin. Immunol. 2003 111 : 313 320.
104. Saito J, Inoue K, Sugawara A, Yoshikawa M, Watanabe K et al. Exhaled nitric oxide as a marker of airway inflammation for an epidemiologic study in schoolchildren. J. Allergy Clin. Immunol. 2004 114 : 512 516.
105. Gratziou C, Lignos M, Dassiou M, Roussos C. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur. Respir. J. 1999 14 : 897 901.
106. Adisesh LA, Kharitonov SA, Yates DH, Snashell DC, Newman-Taylor AJ et al. Exhaled and nasal nitric oxide is increased in laboratory animal allergy. Clin. Exp. Allergy 1998 28 : 876 880.
107. Horvath I, Barnes PJ. Exhaled monoxides in asymptomatic atopic subjects. Clin. Exp. Allergy 1999 29 : 1276 1280.
108. Henriksen AH, Sue-Chu M, Holmen TL, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur. Respir. J. 1999 13 : 301 306.
109. Vahlkvist S, Sinding M, Skamstrup K, Bisgaard H. Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure. J. Allergy Clin Immunol. 2006 117 : 1272 1276.
110. Latzin P, Kuehni CE, Baldwin DN, Roiha HL, Casaulta C et al. Elevated exhaled nitric oxide in newborns of atopic mothers precedes respiratory symptoms. Am. J. Respir. Crit. Care Med. 2006 174 : 1292 1298.
111. van Den Toorn LM, Prins JB, Overbeek SE, Hoogsteden HC, de Jongste JC. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2000 162 : 953 957.
112. Bodini A, Peroni D, Loiacono A, Costella S, Pigozzi R et al. Exhaled nitric oxide daily evaluation is effective in monitoring exposure to relevant allergens in asthmatic children. Chest 2007 132 : 1520 1525.
113. Kanazawa H, Shoji S, Hirata K, Kurthara N, Yoshikawa J. Role of endogenous nitric oxide in airflow obstruction in smokers. Chest 1996 110 : 927 929.
114. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA et al. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 1998 157 : 998 1002.
115. Liu J, Sandrini A, Thurston MC, Yates DH, Thomas PS et al. Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients. Respiration 2007 74 : 617 623.
116. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 2003 167 : 418 424.
117. Kanazawa H, Shoji S, Yoshikawa T, Hirata K, Yoshikawa J. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease. Clin. Exp. Allergy 1998 28 : 1244 1250.
118. Kanazawa H, Shoji S, Yamada M, Fujii T, Kawaguchi T et al. Increased levels of nitric oxide derivatives in induced sputum in patients with asthma. J. Allergy Clin. Immunol. 1997 99 : 624 629.
119. Kharitonov SA, Wells AU, O'Connor BJ, Cole PJ, Hansell DM et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 1995 151 : 1889 1893.
120. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998 53 : 680 684.
121. Wang CH, Liu CY, Lin HC, Yu CT, Chung KF et al. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur. Respir. J. 1998 11 : 809 815.
122. O'Donnell DM, Moynihan J, Finlay GA, Keatings VM, O'Connor CM et al. Exhaled nitric oxide and bronchoalveolar lavage nitrite/nitrate in active pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 1997 156 : 1892 1896.
123. Kharitonov SA, Cailes JB, Black CM, du Bois RM, Barnes PJ. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997 52 : 1051 1055.
124. Wong GW, Liu EK, Leung TF, Yung E, Ko FW et al. High levels and gender difference of exhaled nitric oxide in Chinese schoolchildren. Clin. Exp. Allergy 2005 35 : 889 893.
125. Lex C, Ferreira F, Zacharasiewicz A, Nicholson AG, Haslam PL et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am. J. Respir. Crit. Care Med. 2006 174 : 1286 1291.
126. Warke TJ, Fitch PS, Brown V, Taylor R, Lyons JD et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002 57 : 383 387.
127. Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ et al. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003 58 : 528 532.
128. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am. J. Respir. Crit. Care Med. 2001 164 : 1376 1381.
129. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998 53 : 91 5.
130. Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J. Allergy Clin. Immunol. 2000 106 : 638 644.
131. Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ et al. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin. Exp. Allergy 2005 35 : 1175 1179.
132. Silvestri M, Spallarossa D, Frangova Yourukova V, Battistini E, Fregonese B et al. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma. Eur. Respir. J. 1999 13 : 321 326.
133. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 1993 6 : 1368 1370.
134. Silkoff PE, McClean PA, Slutsky AS, Caramori M, Chapman KR et al. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J. Asthma 1998 35 : 473 479.
135. Persson MG, Zetterstrom O, Agrenius V, Ihre E, Gustafsson LE. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994 343 : 146 147.
136. Frank TL, Adisesh A, Pickering AC, Morrison JF, Wright T et al. Relationship between exhaled nitric oxide and childhood asthma. Am. J. Respir. Crit. Care Med. 1998 158 : 1032 1036.
137. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur. Respir. J. 1996 9 : 196 201.
138. Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am. J. Respir. Crit. Care Med. 2001 164 : 738 743.
139. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS et al. Expired nitric oxide levels during treatment of acute asthma. Am. J. Respir. Crit. Care Med. 1995 152 : 800 803.
140. Silkoff PE, McClean P, Spino M, Erlich L, Slutsky AS et al. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001 119 : 1322 1328.
141. Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999 54 : 108 114. (Pubitemid 29101352)
142. Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur. Respir. J. 2008 31 : 539 546.
143. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C et al. Exhaled nitric oxide: a predictor of steroid response. Am. J. Respir. Crit. Care Med. 2005 172 : 453 459.
144. Ansarin K, Chatkin JM, Ferreira IM, Gutierrez CA, Zamel N et al. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur. Respir. J. 2001 17 : 934 938.
145. Stirling RG, Kharitonov SA, Campbell D, Robinson DS, Durham SR et al. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group. Thorax 1998 53 : 1030 1034.
146. Silkoff PE, Caramori M, Tremblay L, McClean P, Chaparro C et al. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am. J. Respir. Crit. Care Med. 1998 157 : 1822 1828.
147. Gabbay E, Walters EH, Orsida B, Whitford H, Ward C et al. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 2000 162 : 2182 2187.
148. Ludviksdottir D, Janson C, Hogman M, Gudbjornsson B, Bjornsson E et al. Increased nitric oxide in expired air in patients with Sjogren's syndrome. BHR-Study Group. Bronchial hyperresponsiveness. Eur. Respir. J. 1999 13 : 739 743.
149. Ludviksdottir D, Janson C, Hogman M, Hedenstrom H, Bjornsson E et al. Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma. BHR-Study Group. Respir. Med. 1999 93 : 552 556.
150. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003 123 : 751 756.
151. Smith AD, Taylor DR. Is exhaled nitric oxide measurement a useful clinical test in asthma? Curr. Opin. Allergy Clin. Immunol. 2005 5 : 49 56.
152. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am. J. Respir. Crit. Care Med. 2004 169 : 473 478.
153. Taylor DR, Pavord ID. Biomarkers in the assessment and management of airways diseases. Postgrad. Med. J. 2008 84 : 628 634.
154. Robroeks CM, van de Kant KD, Jobsis Q, Hendriks HJ, van Gent R et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin. Exp. Allergy 2007 37 : 1303 1311.
155. Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J. Asthma 2004 41 : 471 476.
156. Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005 60 : 215 218.
157. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am. J. Respir. Crit. Care Med. 2005 171 : 1077 1082.
158. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am. J. Respir. Crit. Care Med. 2000 161 : 64 72.
159. Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J. Allergy Clin. Immunol. 2005 115 : 720 727.
160. Leuppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 2001 163 : 406 412.
161. Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol. 1999 103 : 232 237.
162. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med. 2005 352 : 2163 2173.
163. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2005 172 : 831 836.
164. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2007 176 : 231 237.
165. Ratnawati, Morton J, Henry RL, Thomas PS. Exhaled nitric oxide in management of paediatric asthma. J. Resp. Indon. 2007 27 : 24 36.
166. Fritsch M, Uxa S, Horak F Jr., Putschoegl B, Dehlink E et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr. Pulmonol. 2006 41 : 855 862.
167. Petsky HL, Cates CJ, Li AM, Kynaston JA, Turner C et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst. Rev. 2008 CD006340.
168. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008 372 : 1065 1072.
169. de Jongste JC, Carraro S, Hop WC, Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am. J. Respir. Crit. Care Med. 2009 179 : 93 7.
170. Gibson PG. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for Asthma Treatment Algorithm studies. Clin. Exp. Allergy 2009 39 : 478 490.
171. Hewitt RS, Smith AD, Cowan JO, Schofield JC, Herbison GP et al. Serial exhaled nitric oxide measurements in the assessment of laboratory animal allergy. J. Asthma 2008 45 : 101 107.
172. Chatkin JM, Ansarin K, Silkoff PE, McClean P, Gutierrez C et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am. J. Respir. Crit. Care Med. 1999 159 : 1810 1813.